The fresh capital was raised at the company’s current valuation of $22 billion, two people with knowledge of the development said, requesting anonymity.
In an interview, Raveendran spoke about the delay in filing financials, the accounting changes that led to a drop in FY21 revenue, allegations of mis-selling of products, the company’s fundraising plan, and its aggressive acquisition strategy